Jon Scott Appling, M.D.

4% more Medicare Part D claims than the average family medicine physician in 2024

3,691 Medicare Part D claims for 201 beneficiaries, against an average of 3,544 among the 117,163 providers of this specialty who prescribed in Part D. Brand-name drugs were 14% of claims. 203 claims were for opioids.

Most prescribed

1. Amlodipine Besylate153 claims
2. Levothyroxine Sodium151 claims
3. Gabapentin129 claims
4. Atorvastatin Calcium107 claims
5. Losartan Potassium94 claims
6. Pantoprazole Sodium92 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 79.4 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $205.35

11 payments; by number, the most common kind was food and beverage; the largest payer was Novo Nordisk Inc. The 55,478 providers of this specialty with any payment received $902.55 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.